[1]
B. Kulumbegov, M. Gotua, and T. Chikovani, “Type I and Type IIb Autoimmunity in Chronic Spontaneous Urticaria Patients: Evaluating the Clinical Response to Omalizumab”, GS, vol. 5, no. 2, pp. 109–116, May 2023.